Plant ID: NPO28049
Plant Latin Name: Piper callosum
Taxonomy Genus: Piper
Taxonomy Family: Piperaceae
NCBI TaxonomyDB:
538245
Plant-of-the-World-Online:
680748-1
Brazil; Bolivia; Peru
TAS2R31; | |
TSHR; | |
SLCO1B3; SLCO1B1; | |
LMNA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
SLC superfamily of solute carriers | SLCO1B3 | Solute carrier organic anion transporter family member 1B3 | Q9NPD5 | CHEMBL1743121 |
SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
Taste receptor (taste family GPCR) | TAS2R31 | Taste receptor type 2 member 31 | P59538 | CHEMBL2034804 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 1.917E-10 | 3.521E-06 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 3.210E-09 | 2.330E-05 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 8.380E-09 | 4.562E-05 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 9.264E-08 | 3.362E-04 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0009404; toxin metabolic process | 1.233E-07 | 3.834E-04 | CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0005488; binding | GO:0020037; heme binding | 2.259E-07 | 5.466E-04 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 5.531E-07 | 1.004E-03 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0018894; dibenzo-p-dioxin metabolic process | 1.157E-06 | 1.939E-03 | CYP1A1, CYP1A2 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 3.127E-06 | 4.255E-03 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0050665; hydrogen peroxide biosynthetic process | 5.396E-06 | 6.911E-03 | CYP1A1, CYP1A2 |
MF | GO:0005215; transporter activity | GO:0015125; bile acid transmembrane transporter activity | 2.941E-05 | 2.372E-02 | SLCO1B1, SLCO1B3 |
CC | GO:0016020; membrane | GO:0016323; basolateral plasma membrane | 7.072E-05 | 4.154E-02 | SLCO1B1, SLCO1B3, TSHR |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 5.336E-04 | 1.905E-01 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
CC | GO:0044425; membrane part | GO:0005887; integral component of plasma membrane | 2.331E-02 | 1.000E+00 | SLCO1B1, SLCO1B3, TSHR |
CC | GO:0016020; membrane | GO:0031090; organelle membrane | 2.728E-02 | 1.000E+00 | CYP1A1, CYP1A2, CYP1B1, LMNA |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 7.935E-09 | 1.746E-07 | CYP1A2, CYP1A1, CYP1B1, CYP19A1 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 6.174E-07 | 6.791E-06 | CYP1A2, CYP1A1, CYP1B1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 1.222E-06 | 8.961E-06 | CYP1A1, CYP1B1, CYP19A1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 3.858E-06 | 2.122E-05 | CYP1A2, CYP1A1, CYP1B1 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 5.482E-06 | 2.412E-05 | CYP1A2, CYP1A1, CYP1B1 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 3.690E-04 | 1.353E-03 | CYP1A2, CYP1A1 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 4.402E-04 | 1.383E-03 | SLCO1B1, SLCO1B3 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.502E-02 | 3.305E-02 | CYP1A2, CYP1A1, CYP19A1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.298E-02 | 3.172E-02 | CYP1A2 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 2.248E-03 | 6.183E-03 | CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Advanced breast cancer | C50 | CYP19A1; |
C00-D49: Neoplasms | Breast cancer | C50 | CYP19A1; |
N00-N99: Diseases of the genitourinary system | Endometriosis | N80 | CYP19A1; |
C00-D49: Neoplasms | Bladder cancer | C67 | CYP19A1; |
N00-N99: Diseases of the genitourinary system | Prostate disease | N42.9 | CYP19A1; |
C00-D49: Neoplasms | Hormonally-responsive breast cancer | C50 | CYP19A1; |